Charles River Laboratories International () Debt/EBITDA US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | 3.14 | 2.48 | 3.27 | 2.90 | 2.70 | 2.58 | |||
Changes by years, y/y, % | -13% | -21% | +32% | -11% | -7% | -5.5% |
Charles River Laboratories International. Debt/EBITDA
Charles River Laboratories International. Debt/EBITDA, changes, %
Charles River Laboratories International () Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
Debt/EBITDA | 2.58 | 2.05 | 2.70 | 2.70 | 2.58 | 2.58 | ||
Changes by years, y/y, % | -22% | -29% | +13% | +31% | 0% | |||
Changes by quarters, q/q, % | +25% | -21% | +32% | 0% | -4% |